In partnership with ISSUP Global, ISSUP South Africa presented a webinar on COVID-19: What can be done through us

Date: Wednesday, June 3, 2020

Presenter: David Bayever

David Bayever serves on the SAPharmacy Council as an Assessor, Examiner and Researcher. He is currently the Chairperson of South Africa's Central Drug Authority, and he also serves as a Member of SAHPRA Cannabis Working Committee and Member of Technical Task Team on Public Health     Dimensions of Narcotic Drugs and Psychotropic Substance Problems. David is a member of DoH Ministerial Advisory Committee on Cannabis. He is...

The Prevention, Treatment & Rehabilitation Section (PTRS) of UNODC developed a questionnaire to gather insights into the current challenges and responses to COVID-19 and the continuity of drug treatment services.

The questionnaire is intended for treatment service providers and it looks at the impact of the delivery of treatment services and the measures of adaptation to the COVID-19 crisis, specifically what has been done in different places that have proven useful for service continuity.

PTRS is collecting the answers to this questionnaire to measure the impact of the COVID-19 pandemic on...

This document provides guidance to African Union Member States on key mental health and psychosocial support (MHPSS) considerations in relation to the coronavirus disease 2019 (COVID-19) pandemic.

It contains useful guidance on MHPSS for the community, healthcare workers, caregivers of vulnerable populations and people in quarantine, isolation or treatment centres.

This guidance aims to provide practical steps to reduce stress, anxiety, stigma and psychological disorders associated with COVID-19 and improve overall mental health and well being.

The document is designed to be used for...

Webinar on Good Practices in Mental Health Care in Residential Centers in Context of COVID-19

Internal work agenda

On 22 May 2020, ISSUP Argentina collaborated with ISSUP Global to present a webinar on quarantined working conditions, pandemics and addictions.

Exhibitors: Dres. Roberto Canay and Ernesto Eduardo González
University of the Argentine Social Museum (UMSA)

In the early 2020s, with the COVID 19 pandemic and mandatory quarantine, there has been a large proliferation of workplace consequences and its new adaptation schemes, such as telework. This presentation documented the consequences and effects of these realities and how they affect workers, from an analysis perspective, with the aim of...

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.

However, those with underlying medical problems are more likely to develop serious illness.

In this article Dr. Volkow discusses how the serious health risks of COVID-19 pose unique challenges to people who smoke or vape, are already struggling with substance use disorders (SUD), or are in recovery from addiction.